Jésus, Jean Baptiste, et tous les autres

(Résumé du numéro) Que sait-on exactement de Jésus aujourd'hui? Du monde dans lequel il a vécu? De ses rapports avec les différents courants religieux du judaïsme? Quelles sont les sources dont nous disposons? Comment le souvenir de Jésus s'est-il transmis? En réalité, Beaucoup plus que pour tout autre prophète ou maître juif du Ier siècle, et au moins autant que n'importe quel grand personnage de l'Antiquité. Les évangiles eux-mêmes ont été soumis à de nombreuses enquêtes critiques, historiques, archéologiques et linguistiques, comme aucun autre texte de l'Antiquité ! Nous avons demandé aux spécialistes des textes évangéliques et apocryphes, aux historiens de la Palestine du Ier siècle, aux archéologues, de dresser avec nous un bilan de nos connaissances.

Vulgariser les sciences sans l'appui des savants. Jean Lanteires et le Journal de Lausanne (1786-1792)

Popularizing science without the support of scholars. Jean Lanteires and the Journal de Lausanne (1786-1792). - Founded in 1786 by Jean Lanteires, the Journal de Lausanne is a widespread, weekly journal with the express aim of disseminating scientific knowledge among the lower and middle classes. Its articles are easily comprehensible and cover a wide range of topics from literature to agriculture, from natural sciences to charity. Considerable space is given to reader's questions and comments. The journal can be situated somewhere between an almanac and a scientific journal. Lanteires' attempt to solicit contributions from scholars of medicine and natural sciences received a dismissive response. Of the few articles written by specialists, the majority deal with agriculture and charity. Lanteires' difficult relationship with the scholarly community is reflected in the journal's content. This makes the Journal de Lausanne a privileged observatory for studying the social context of the vulgarization process in late-eighteenth-century Switzerland and Europe.

La caisse unique n'est pas la potion miracle pour notre système de santé : [interview de Jean-Pierre Danthine et Michel Mougeot]

La prime d'assurance maladie reste un instrument de régulation intéressant à l'heure où tous les pays tâtonnent pour trouver le meilleur arbitrage entre qualité des soins et montant des dépenses. [Auteur]

Ubiquitination of the Epstein-Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site.

The latent membrane protein 1 (LMP1) encoded by the Epstein-Barr virus functions as a constitutively activated receptor of the tumor necrosis factor receptor family. LMP1 is a short-lived protein that is ubiquitinated and degraded by the proteasome. We have previously shown that LMP1 recruits the adapter protein tumor necrosis factor receptor-associated factor 3 (TRAF3) to lipid rafts. To test if TRAFs are involved in LMP1's ubiquitination, we have mutated the LMP1 CTAR1 site that has been identified as a TRAF binding site. We show that the CTAR1 mutant (CTAR1(-)) is expressed after transfection at a similar level to wild-type LMP1, and behaves as wild-type LMP1 with respect to membrane localization. However, CTAR1(-) does not bind TRAF3. We demonstrate that ubiquitination of CTAR1(-) is significantly reduced when compared to wild-type LMP1. In addition, the expression of wild-type LMP1 induces the ubiquitination, an effect that is significantly reduced when the CTAR1(-) is expressed. Taken together, our results suggest that TRAF proteins are involved in the ubiquitination of LMP1, and that their binding to LMP1 may facilitate their own ubiquitination.